Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8433089 | Cancer Epidemiology | 2016 | 8 Pages |
Abstract
The incidence rates of advanced-stage breast cancers decreased in the age groups from 55 years to the upper age limit for screening eligibility, but not in the adjacent age groups. The findings are consistent with MSP lead time effects and seem to indicate that the MSP lowers advanced-stage breast cancer rates in the target population.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Alexandra Simbrich, Ina Wellmann, Jan Heidrich, Oliver Heidinger, Hans-Werner Hense,